相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Non-invasive clinical and microscopic evaluation of the response to treatment with clobetasol cream vs. calcipotriol/betamethasone dipropionate foam in mild to moderate plaque psoriasis: an investigator-initiated, phase IV, unicentric, open, randomized clinical trial
O. Yelamos et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Vasoconstrictor potency of fixed-dose combination calcipotriol (50 μg/g) and betamethasone dipropionate (0.5 mg/g) cutaneous foam versus other topical corticosteroids used to treat psoriasis vulgaris
C. Queille-Roussel et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2019)
Medicated Foams and Film Forming Dosage Forms as Tools to Improve the Thermodynamic Activity of Drugs to be Administered Through the Skin
Chiara G. M. Gennari et al.
CURRENT DRUG DELIVERY (2019)
Optimizing Anti-Inflammatory and Immunomodulatory Effects of Corticosteroid and Vitamin D Analogue Fixed-Dose Combination Therapy
Siegfried Segaert et al.
DERMATOLOGY AND THERAPY (2017)
A Novel Aerosol Foam Formulation of Calcipotriol and Betamethasone Has No Impact on HPA Axis and Calcium Homeostasis in Patients With Extensive Psoriasis Vulgaris
Victoria Taraska et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2016)
Drug crystallization - implications for topical and transdermal delivery
Jonathan Hadgraft et al.
EXPERT OPINION ON DRUG DELIVERY (2016)
Enhanced vasoconstrictor potency of the fixed combination calcipotriol plus betamethasone dipropionate in an innovative aerosol foam formulation vs. other corticosteroid psoriasis treatments
C. Queille-Roussel et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
Supersaturation of Calcipotriene and Betamethasone Dipropionate in a Novel Aerosol Foam Formulation for Topical Treatment of Psoriasis Provides Enhanced Bioavailability of the Active Ingredients
Marianne Lind et al.
DERMATOLOGY AND THERAPY (2016)
Efficacy of an Innovative Aerosol Foam Formulation of Fixed Combination Calcipotriol plus Betamethasone Dipropionate in Patients with Psoriasis Vulgaris
Catherine Queille-Roussel et al.
CLINICAL DRUG INVESTIGATION (2015)
Calcipotriol counteracts betamethasone-induced decrease in extracellular matrix components related to skin atrophy
Hanne Norsgaard et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2014)
Topical steroid risk analysis: Differentiating between physiologic and pathologic adrenal suppression
Ethan Levin et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2014)
Systemic Side-Effects of Topical Corticosteroids
Sandipan Dhar et al.
INDIAN JOURNAL OF DERMATOLOGY (2014)
Guidelines of care for the management of psoriasis and psoriatic arthritis
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Guidelines of care for the management of psoriasis and psoriatic arthritis Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission
JR Lindsay et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
分享论文
